Comparison of Bacterial Risk in Cryo AHF and Pathogen Reduced Cryoprecipitated Fibrinogen Complex

Until November 2020, cryoprecipitated antihaemophilic factor (cryo AHF) was the only United States Food and Drug Administration (FDA)-approved fibrinogen source to treat acquired bleeding. The post-thaw shelf life of cryo AHF is limited, in part, by infectious disease risk. Concerns over product was...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Thea, Nahata, Pallavi, Johnson, Aja, Keltner, Nadia, Peters, Lindsay, McCormack, Melissa, Muñoz, Bianca, Krath, Mary, Weiner, Elan, Bringmann, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317717/
https://www.ncbi.nlm.nih.gov/pubmed/35889990
http://dx.doi.org/10.3390/pathogens11070744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317717/
https://www.ncbi.nlm.nih.gov/pubmed/35889990
http://dx.doi.org/10.3390/pathogens11070744

Ejemplares similares